Advanced Search

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1) (PB 7 of 2016)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 7 of 2016
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1)
National Health Act 1953
I, DIANNA PROSSER, Assistant Secretary (Acting), Pharmaceutical Policy Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated      28       January 2016
 
 
 
 
 
 
 
 
 
DIANNA PROSSER
 
Assistant Secretary (Acting)
Pharmaceutical Policy Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1).
         (2)   This Determination may also be cited as PB 7 of 2016.
2              Commencement
                This Determination commences on 1 February 2016.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Apixaban
 
Omit
 
Apomorphine
 
[2]     Schedule 1, after item dealing with Rotigotine
 
Insert
 
Ruxolitinib
 
[3]     Schedule 1, after item dealing with Vitamins, minerals and trace elements with carbohydrate
 
Omit
 
Voriconazole
 
[4]     Schedule 2, after item dealing with Anastrozole
 
Insert
 
Apomorphine
 
[5]     Schedule 2, after item dealing with Vinorelbine
 
Insert
 
Voriconazole